LOVE Share Price Performance
CA$1.71
0.45 (35.71%)
46.4% undervalued intrinsic discount
CA$3.19
Fair Value
Price CA$1.71
AnalystConsensusTarget CA$3.19
Fair ValueCA$3.19
Share Pricen/a
New Narrative • Apr 25
Cannara Biotech Inc. Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 16 Fair Values set on narratives written by author
LOVE Community Narratives
AN
Fair Value
·Fair Value CA$3.19 46.4% undervalued intrinsic discount
Expanded Capacity And EU Export Optionality Will Support Long Term Premium Cannabis Demand
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Expanded Capacity And EU Export Optionality Will Support Long Term Premium Cannabis Demand
Catalysts About Cannara Biotech Cannara Biotech is a vertically integrated Canadian cannabis producer focused on premium branded products at competitive price points. What are the underlying business or industry changes driving this perspective?Read more
AN
CA$3.19
46.4% undervalued intrinsic discount
Fair Value
Revenue
15.66% p.a.
Profit Margin
20.77%
Future PE
12.94x
Price in 2029
CA$3.77
Trending Discussion
Recently Updated Narratives
AN
Expanded Capacity And EU Export Optionality Will Support Long Term Premium Cannabis Demand
Fair Value: CA$3.19 46.4% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Cannara Biotech Inc. Key Details
About LOVE
- Founded
- 2017
- Employees
- 452
- CEO
- WebsiteView website
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORCHID CBD brand name. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.
